Repros Therapeutics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Articles

About This Stock More About This Stock
U.S. Stocks Switched Between Small Gains And Losses
Article By: BioMedReports
Friday, November 7, 2014 4:36 PM EDT
With the main benchmarks hovering near record levels in the wake of a solid jobs report, a key payrolls data showed the economy added 214,000 jobs in October, while the unemployment rate ticked down to 5.8% — a broadly positive reading.
In this article: HGR, ISIS, OSIR, RPRX, MDRX
Read
FDA Continues To Quash Interest In Repros Therapeutics
Article By: PropThink
Friday, October 17, 2014 6:10 PM EDT
FDA put the brakes on Repros Therapeutics (RPRX) on Friday when it indicated that an upcoming meeting would not be the pre-NDA meeting investors expected. The stock dropped 40% in early trading.
In this article: RPRX
Read
Active Stocks: TTPH, RPRX, HZNP, THRX, MYGN
Article By: BioMedReports
Friday, October 17, 2014 5:12 PM EDT
U.S. stocks rallied Friday, extending a string of sharp moves, amid upbeat economic news from the U.S. and rising hopes for more stimulus from global central banks.
In this article: RPRX, THRX, HZNP, MYGN, TTPH
Read
Healthcare Review: GENE, PGNX, RPRX, TKMR, THLD
Article By: BioMedReports
Wednesday, September 24, 2014 12:30 PM EDT
U.S. stocks fell on Monday, with the Dow Jones Industrial Average stepping back from an all-time high, as uncertainty about China's growth injected caution into global markets.
In this article: GENE, PGNX, RPRX, TKMR, THLD
Read
Laidlaw's Yale Jen: Biotech 101 For Buyers And Sellers
Article By: The Life Sciences Report
Friday, August 29, 2014 5:36 AM EDT
Former biotech consultant Yale Jen picked up a few tricks advising companies on their pipelines before he came to Wall Street as a sellside analyst.
In this article: GSK, PFE, ISIS, RPRX, BIIB, MSTX, ADMA, GLYC
Read

Latest Tweets for $RPRX

No tweets yet!

PARTNER HEADLINES